ciprofloxacin has been researched along with cilastatin in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (7.41) | 18.7374 |
| 1990's | 12 (44.44) | 18.2507 |
| 2000's | 11 (40.74) | 29.6817 |
| 2010's | 2 (7.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Bradshaw, MW; Harris, RL; Williams, TW; Zighelboim, J | 1 |
| Kletchko, S; Nagappan, R | 1 |
| Jacobus, NV; Petersen, PJ; Testa, RT; Weiss, WJ | 1 |
| Baetz, R; Borner, K; Lebahn, K; Lode, H; Olschewski, P; Reinke, M; Sievers, H; Wagner, J; Wiley, E; Wintermantel, M | 1 |
| Flint, NB; Tartaglione, TA | 1 |
| Borner, K; Höffken, G; Lode, H; Wagner, J; Wiley, R | 1 |
| Caldwell, JW; Fink, MP; Heard, SO; Johnson, RH; Leeper, KV; Niederman, MS; Schentag, JJ; Siami, GA; Snydman, DR; Wunderink, RG | 1 |
| Bolash, NK; Liu, HH; Lynch, RA; McAnany, ME | 1 |
| Fink, M; Niederman, M; Reinhart, H; Snydman, D | 1 |
| Bjornson, HS; Bohnen, JM; Coulter, HO; Dellinger, EP; Echols, RM; Haverstock, DC; Hill, CS; Reinhart, HH; Rotstein, OD; Simms, HH; Solomkin, JS; Vogel, SB | 1 |
| Adhikari, M; Pillay, DG; Pillay, T; Sturm, AW | 1 |
| Desaty, TM; Griffin, TJ; Heifetz, CL; Sesnie, JC; Shapiro, MA | 1 |
| Gabriel, V; Garbino, J; Harbarth, S; Lew, D; Pittet, D | 1 |
| Paladino, JA; Solomkin, JS; Walters, DJ | 1 |
| Alvarez-Lerma, F; Bauer, TT; Blanquer, J; Castillo, F; Leal-Noval, SR; León-Gil, C; Martínez-Pellús, A; Nadal, P; Palomar, M; Ros, F; Torres, A | 1 |
| Higashiyama, Y; Hirakata, Y; Kadota, JI; Kakeya, H; Kaneko, Y; Kohno, S; Kuroki, M; Miyazaki, Y; Ohi, H; Tomono, K; Yanagihara, K | 1 |
| Fukuda, H; Kawamura, Y | 1 |
| Boulanger, BR; Fogarty, C; Fowler, C; Kahn, JB; Morgan, N; Oross, M; Tennenberg, A; West, M; Wiesinger, B; Wu, SC | 1 |
| Aoki, S; Gotoh, N; Hirakata, Y; Kamihira, S; Kohno, S; Kondoh, A; Miyazaki, Y; Tomono, K; Yamada, Y; Yanagihara, K | 1 |
| Dünser, M; Hasibeder, W; Mayr, AJ; Rieger, M | 1 |
| Kollef, MH; Shorr, AF; Susla, GB | 1 |
| Gfröer, S; Knabbe, C; Rahmig, H; Schroeppel, K; Susa, M; Weile, J | 1 |
| Asaoka, N; Honda, Y; Kibayashi, T; Kishimoto, M; Kurihara, T; Nanba, F; Okimoto, N; Osaki, K; Yamato, K | 1 |
| Joskowiak, D; Kappert, U; Matschke, K; Tugtekin, SM | 1 |
| Chen, CH; Lin, CH; Lin, JS | 1 |
1 review(s) available for ciprofloxacin and cilastatin
| Article | Year |
|---|---|
Quinolones for treatment of nosocomial pneumonia: a meta-analysis.
Topics: Anti-Infective Agents; Cilastatin; Ciprofloxacin; Cross Infection; Humans; Imipenem; Levofloxacin; Meta-Analysis as Topic; Ofloxacin; Pneumonia, Bacterial; Quinolones; Randomized Controlled Trials as Topic | 2005 |
9 trial(s) available for ciprofloxacin and cilastatin
| Article | Year |
|---|---|
Prospective randomized clinical trials of new quinolones versus beta-lactam antibiotics in lower respiratory tract infections.
Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Clavulanic Acids; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Ofloxacin; Pneumonia; Prospective Studies; Remission Induction; Respiratory Tract Infections; Sepsis; Ticarcillin | 1990 |
Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Cilastatin; Ciprofloxacin; Clinical Trials as Topic; Cyclopropanes; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Random Allocation; Thienamycins | 1987 |
Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.
Topics: Adult; Aged; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Double-Blind Method; Drug Combinations; Drug Resistance, Microbial; Female; Hospitalization; Humans; Imipenem; Injections, Intravenous; Male; Middle Aged; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Regression Analysis; Seizures | 1994 |
Susceptibility of bacterial isolates from complicated skin and skin structure infections to cefazolin, imipenem-cilastatin, ciprofloxacin and ofloxacin.
Topics: Adolescent; Adult; Anti-Infective Agents; Bacteria; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Ofloxacin; Skin Diseases, Bacterial; Soft Tissue Infections | 1995 |
Treatment of severe pneumonia in hospitalised patients. Results of a multicentre trial comparing i.v. ciprofloxacin with imipenem/cilastatin.
Topics: Aged; Anti-Infective Agents; APACHE; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Female; Hospitalization; Humans; Imipenem; Male; Middle Aged; Pneumonia; Prospective Studies | 1995 |
Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group.
Topics: Abdomen; Administration, Oral; Adolescent; Adult; Aged; Anti-Infective Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Humans; Imipenem; Infections; Infusions, Intravenous; Metronidazole; Middle Aged; Treatment Outcome | 1996 |
Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections.
Topics: Abdomen; Aged; Anti-Infective Agents; Bacterial Infections; Cilastatin; Ciprofloxacin; Cost-Benefit Analysis; Double-Blind Method; Drug Combinations; Female; Humans; Imipenem; Male; Metronidazole; Middle Aged; Protease Inhibitors; Thienamycins | 1999 |
Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin.
Topics: Adult; Aged; Anti-Infective Agents; Cilastatin; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Female; Humans; Imipenem; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Protease Inhibitors; Survival Rate; Thienamycins; Treatment Outcome | 2000 |
Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study.
Topics: Adult; Aged; Anti-Bacterial Agents; Cilastatin; Ciprofloxacin; Cross Infection; Drug Therapy, Combination; Female; Humans; Imipenem; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Staphylococcal; Prospective Studies; Pseudomonas aeruginosa | 2003 |
17 other study(ies) available for ciprofloxacin and cilastatin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Successful medical management of a patient with multiple hepatic abscesses due to Edwardsiella tarda.
Topics: Adult; Ceftriaxone; Cilastatin; Ciprofloxacin; Drug Therapy, Combination; Enterobacteriaceae Infections; Humans; Imipenem; Liver Abscess; Male | 1992 |
Bilateral emphysematous pyelonephritis resolving to medical therapy.
Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Drug Combinations; Emphysema; Escherichia coli Infections; Female; Humans; Imipenem; Middle Aged; Pyelonephritis; Tomography, X-Ray Computed | 1992 |
In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I.
Topics: Amikacin; Animals; Bacterial Infections; Bacteroides fragilis; Carbapenems; Ceftazidime; Cilastatin; Ciprofloxacin; Dipeptidases; Drug Therapy, Combination; Escherichia coli; Female; Imipenem; Klebsiella pneumoniae; Metronidazole; Mice; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Staphylococcus; Streptococcus; Thienamycins | 1991 |
Effect of imipenem-cilastatin and ciprofloxacin on tests for glycosuria.
Topics: Cefazolin; Cilastatin; Ciprofloxacin; Cyclopropanes; Drug Interactions; False Negative Reactions; Glycosuria; Humans; Imipenem; Quinolines; Thienamycins | 1985 |
Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates.
Topics: Anti-Infective Agents; beta-Lactamase Inhibitors; Cilastatin; Ciprofloxacin; Cross Infection; Drug Combinations; Drug Resistance, Microbial; Drug Resistance, Multiple; Enzyme Inhibitors; Female; Humans; Imipenem; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Protease Inhibitors; Retrospective Studies; Tazobactam; Thienamycins | 1998 |
Comparative therapeutic efficacy of clinafloxacin in a Pseudomonas aeruginosa mouse renal abscess model.
Topics: Abscess; Animals; Anti-Infective Agents; Area Under Curve; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Fluoroquinolones; Half-Life; Imipenem; Kidney; Kidney Diseases; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolones; Treatment Outcome | 1998 |
Cefepime--assessment of its need at a tertiary care center.
Topics: Adult; Aged; Anti-Infective Agents; Cefepime; Ceftazidime; Cephalosporins; Cilastatin; Ciprofloxacin; Cohort Studies; Drug Utilization Review; Female; Hospitals, University; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Switzerland; Thienamycins | 1998 |
Effects of parenterally administered ciprofloxacin in a murine model of pulmonary Pseudomonas aeruginosa infection mimicking ventilator-associated pneumonia.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Cefozopran; Cephalosporins; Cilastatin; Ciprofloxacin; Disease Models, Animal; Imipenem; Infusions, Parenteral; Male; Mice; Pneumonia, Bacterial; Protease Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Respiration, Artificial; Thienamycins | 2001 |
[Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; beta-Alanine; Biphenyl Compounds; Cefazolin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Convulsants; Drug Combinations; Drug Interactions; Enoxacin; Fleroxacin; Fluoroquinolones; Imipenem; Injections, Intravenous; Injections, Intraventricular; Male; Mice; Mice, Inbred ICR; Norfloxacin; Oxazines; Penicillin G; Quinolones; Seizures; Thienamycins | 2002 |
Virulence of metallo-beta-lactamase-producing Pseudomonas aeruginosa in vitro and in vivo.
Topics: Animals; Bacteremia; beta-Lactamases; Ceftazidime; Cephalosporins; Cilastatin; Ciprofloxacin; Drug Therapy, Combination; Imipenem; Leukopenia; Male; Mice; Mice, Inbred BALB C; Protease Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Stem Cells; Thienamycins | 2004 |
Successful therapy of severe pneumonia-associated ARDS after pneumonectomy with ECMO and steroids.
Topics: Anti-Inflammatory Agents; Bronchial Fistula; Carcinoma, Bronchogenic; Cilastatin; Ciprofloxacin; Combined Modality Therapy; Drug Therapy, Combination; Extracorporeal Membrane Oxygenation; Humans; Hypoxia; Imipenem; Lung Neoplasms; Male; Methylprednisolone; Middle Aged; Pneumonectomy; Pneumonia; Positive-Pressure Respiration; Postoperative Complications; Reoperation; Respiratory Distress Syndrome | 2004 |
First detection of a VIM-1 metallo-beta-lactamase in a carbapenem-resistant Citrobacter freundii clinical isolate in an acute hospital in Germany.
Topics: Aged, 80 and over; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cilastatin; Ciprofloxacin; Citrobacter freundii; Enterobacteriaceae Infections; Female; Germany; Humans; Imipenem; Polymerase Chain Reaction | 2007 |
[Study of the cases with multidrug-resistant Pseudomonas aeruginosa by sputum culture].
Topics: Adult; Aged; Amikacin; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; Hospitals, University; Humans; Imipenem; Japan; Klebsiella pneumoniae; Male; Methicillin Resistance; Middle Aged; Pneumonia, Bacterial; Prognosis; Pseudomonas aeruginosa; Retrospective Studies; Sputum; Staphylococcus aureus; Time Factors | 2007 |
Ruptured pulmonary artery caused by isolated pulmonary valve endocarditis: case report.
Topics: Aged; Aneurysm, Ruptured; Anti-Bacterial Agents; Anti-Infective Agents; Carcinoma, Hepatocellular; Cilastatin; Ciprofloxacin; Endocarditis, Bacterial; Fatal Outcome; Hepatectomy; Humans; Imipenem; Liver Neoplasms; Male; Protease Inhibitors; Pulmonary Artery; Pulmonary Valve; Rupture, Spontaneous; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2010 |
Bacteremia caused by Elizabethkingia meningoseptica in a mechanically ventilated patient successfully treated with imipenem-cilastatin and ciprofloxacin.
Topics: Anti-Bacterial Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Flavobacteriaceae Infections; Humans; Imipenem; Male; Middle Aged | 2017 |